30 Day Trial

Zyga Enrolls First Patients in Expanded Clinical Study on Sacroiliac Joint Fusion


Zyga Technology enrolled the first four patients in an expanded EVoluSIon Clinical Study. The prospective 40-site, 250-patient trial will evaluate long-term fusion and pain reduction in patients receiving SImmetry® Sacroiliac Joint Fusion.

The company cited figures from Expert Review of Neurotherapeutics, reporting that ~20% of all chronic low back pain derives from the sacroiliac joint.

Source: Zyga Technology, Inc.

Initial enrollment of an earlier U.S. 10-site EVoluSIon Study commenced in 1Q15. Zyga was among companies helping to fuel the lively discussion of SI joint treatment at the NASS meeting in 2015, as well.